Search for: "Bayer v. Bayer" Results 761 - 780 of 1,122
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Oct 2012, 7:39 am by Victoria VanBuren
Disputing, July 16, 2012 USADA Case against Lance Armstrong | USADA Allegations, Disputing, July 13, 2012 Lance Armstrong | The Doping Controversy Continues, Disputing, July 12, 2012 Jeremy Clare is a law clerk at Karl Bayer, Dispute Resolution Expert. [read post]
29 Aug 2012, 9:33 pm by Victoria VanBuren
Disputing, July 16, 2012 USADA Case against Lance Armstrong | USADA Allegations, Disputing, July 13, 2012 Lance Armstrong | The Doping Controversy Continues, Disputing, July 12, 2012 Jeremy Clare is a law clerk at Karl Bayer, Dispute Resolution Expert. [read post]
28 Dec 2021, 1:48 am by Rose Hughes
(T 966/18) (14 July 2021)Bayer v Teva: Drug fo [read post]
7 May 2010, 5:00 am by Victoria VanBuren
For more on this topic, see our series on conflict resolution in health care here (Part I, II, III, IV, and V). [read post]
2 Apr 2010, 5:00 am by Victoria VanBuren
For more on using mediation techniques in healthcare, see our Part III, Part IV and Part V. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Infosint (IPKat) (PatLit) Clobex (Clobetasol) – US: Galderma, Dermalogix agree to end Clobex suit with Paddock (Patent Docs) Crestor (Rosuvastatin) – US: Palmetto files patent infringement suit against AstraZeneca based on its Crestor product; AstraZeneca files for declaratory judgment of non-infringement and invalidity (Patent Docs) Drospirenone, Ethinylestradiol – UK: Shedding further light on obviousness: Gedeon Richter PC v Bayer Schering Pharma AG (Kluwer… [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]